Curaleaf Launches Share Repurchase Program
Curaleaf Launches Share Repurchase Program |
| [16-April-2026] |
STAMFORD, Conn., April 16, 2026 /PRNewswire/ -- Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer cannabis products, has announced that its Board of Directors has authorized, and the Toronto Stock Exchange ("TSX") has approved, the Company to commence a normal course issuer bid ("NCIB" or the "Bid") to repurchase up to 34,388,831 of its subordinate voting shares (the "Subordinate Voting Shares") over the twelve-month period commencing on April 20, 2026 and ending no later than April 19, 2027, representing approximately 5% of the Subordinate Voting Shares issued and outstanding as of April 10, 2026, or an aggregate fair market value of approximately U.S.$83 million based on the closing trading price of the Subordinate Voting Shares on the TSX on April 14, 20261. As of April 10, 2026, there were 687,776,631 Subordinate Voting Shares issued and outstanding. "This share repurchase program is a meaningful way to return value to our shareholders and reflects our confidence in the strength and durability of our strategy," said Boris Jordan, Chairman and CEO of Curaleaf. The NCIB will be conducted through the facilities of the TSX and/or alternative trading systems in Canada, if eligible, from time to time over the term of the Bid and will conform to their regulations. The Company believes that, from time to time, the Subordinate Voting Shares may trade in a price range that does not fully reflect their value. The Company believes that in such circumstances, the repurchase of its Subordinate Voting Shares represents an appropriate use of its available funds. The Bid provides the Company with the flexibility to acquire Subordinate Voting Shares when market conditions are favorable, consistent with a disciplined approach and applicable regulatory requirements. Under the NCIB, other than purchases made under block purchase exemptions, Curaleaf will be allowed, subject to applicable securities laws, to purchase daily, through the facilities of the TSX, a maximum of 210,139 Subordinate Voting Shares representing 25% of the average daily trading volume of 840,559 Subordinate Voting Shares, as calculated per the TSX rules for the six-month period ended on March 31, 2026. The Company has appointed ATB Cormark Capital Markets as its designated broker under the NCIB. The actual number of Subordinate Voting Shares purchased, timing of purchases, and share price will be determined based on market conditions and in accordance with applicable securities laws. The NCIB does not obligate Curaleaf to acquire a specific dollar amount or number of shares and may be modified or discontinued at any time in accordance with securities legislation and TSX rules. Subordinate Voting Shares will be acquired under the NCIB at the prevailing market price at the time of acquisition. Purchases under the NCIB are expected to commence after Curaleaf releases financial results in respect of its first quarter ended March 31, 2026. Any Subordinate Voting Share purchased under the NCIB will be canceled. Curaleaf has not purchased any of its outstanding Subordinate Voting Shares under a normal course issuer bid in the past 12 months. About Curaleaf Holdings Forward Looking Statements Investor Contact: Media Contact: 1 Being C$3.32 per Subordinate Voting Share, equivalent to U.S.$2.4163 per Subordinate Voting Share using the exchange rate published by the Bank of Canada of C$1.00; U.S.$0.7278 on such date.
SOURCE Curaleaf Holdings, Inc. | ||
Company Codes: CNSX:CURA,OTC-PINK:CURLF,OTC-BB:CURLF,OTCQX:CURLF,Toronto:CURA |












